Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lactobacillus GG to Enhance the Immunogenicity of Influenza Vaccine in Healthy Adults - Proof of Concept Study

NCT00620412 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT00620412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00620412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lactobacillus GG to Enhance the Immunogenicity of Influenza Vaccine in Healthy Adults - Proof of Concept Study
Lead sponsor
Tufts Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2007
Completion date
December 31, 2009
Enrollment
52 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy